Contacts: Anthony G. Viscogliosi, (212) 583-9700 ext. 100
Nick Kilsby, Creative Partners PR, (203) 705-9202


NEW YORK, NY: December 14, 2007 – Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone and joint sector of the orthopedic industry, has appointed Michael L. Consilvio as Director of Marketing. The position was created by the recent promotion of Christopher J. Frederick to Senior Vice President, Worldwide Sales & Marketing of SBi.

Mr. Consilvio brings to SBi more than 20 years of sales and marketing experience, principally in the orthopedic device industry. Reporting to Mr. Frederick and based in SBi’s Morrisville, Penn. offices, Mr. Consilvio will be responsible for developing and managing the SBi brand in the US, including communications programs supporting the company’s 60-plus Total Technology Systems for treating disease and trauma reconstruction in bones and joints from the tips of the fingers to the shoulder, and from below the knee to the toes.

Anthony G. Viscogliosi, Chairman & CEO of SBi, said: “Mr. Consilvio’s accomplishments in the orthopedic device industry will be extremely valuable in supporting our vision to be a global leader by fulfilling SBi’s mission to create dominant franchise value as the first to focus exclusively on the $1.7 billion small bone and joint sector.”

Prior to joining SBi, Mr. Consilvio spent seven years with the Musculoskeletal Transplant Foundation (MTF) of Edison, NJ where he was a Product Manager and Group Product Director. Before MTF, Mr. Consilvio was a Product Manager at EBI Medical Systems, Parsippany, NJ and prior to that had sales positions with Bausch & Lomb’s Polymer Technology division in Wilmington, MA and Smith & Nephew in Memphis, TN.

He began his career in 1996 at Merrill Lynch in New York as an account representative and then Technology Analyst.

Mr. Consilvio holds a MBA in Corporate Finance from Fairleigh Dickinson University and a BA in Economics from New York University at Oneonta.

About Small Bone Innovations, Inc.

Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal/orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi can offer a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has more than 130 employees at facilities in New York, NY, Morrisville, PA, and Bourg-en-Bresse, France.

SBi closed on the sale of $42.2 million of its securities in December 2005. At the time, based on data provided by Venture Source, it was the largest venture capital investment ever recorded in the field of orthopedic devices.

On October 24, 2007, international business consultants, Frost & Sullivan selected SBi . as the recipient of the 2007 North American Frost & Sullivan Award for Entrepreneurial Company of the Year. Frost & Sullivan cited SBi “for its focus on tissue-based and ‘life-altering’ treatment technologies that has established their position in the $35 billion and still growing orthopedic industry.”

In addition, SBi was a 2007 recipient of Red Herring magazine’s first Red Herring 100 Global Award, recognizing SBi as one of the world’s leading startup companies and the only orthopedic device company selected among a field of more than 1,800 firms. The company had previously been named in the Red Herring 100 Top North American technology companies in 2006.

Additionally, SBi’s Artelon® CMC-I Spacer, developed for patients with osteoarthritis at the base of the thumb, was featured on the cover and highlighted within Medical Design Technology magazine’s “Year of Innovation” issue as one of the most fascinating technologies influencing the medical device industry.

Medical Device & Diagnostic Industry magazine named SBi to its list of “50 Companies to Watch” in 2006, noting, “Small Bone Innovations is going against the grain in its determination to become a market leader in the small bone & joint device sector.”
For more information on SBi, please visit:

About Viscogliosi Bros., LLC

Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.

Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on “life changing” musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships, and significant financial expertise in the musculoskeletal/ orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing billions of dollars through the orthopedics industry. VB has pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.

> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.